The promise and peril of chemical probesC.H. Arrowsmith, Michael A. Walters, C. Bountra et al.|Nature Chemical Biology|2015Cited by 848
Preclinical target validation using patient-derived cellsA.M. Edwards, Kevin Petrecca, C.H. Arrowsmith et al.|Nature Reviews Drug Discovery|2015Cited by 54
Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney diseaseBarry J. Zimmerman, Mark E. Bunnage|Nature Communications|2025Cited by 18